Abstract
Ultraviolet B (UVB) is a highly effective, relatively safe, affordable and widely used therapeutic option for moderate psoriasis. Several types of UVB lamp are available to treat psoriasis, both broadband and narrowband, allowing a choice of spectral emission. However despite years of clinical use, the mechanism of action of UVB in clearing psoriasis remained incompletely understood. Moreover, there has been little insight into how the relative effectiveness of different UVB wavelengths linked to the mechanism of action, although it is known that the action spectrum for clearance of psoriasis differs from the action spectrum of erythema. This paper examines the existing literature from which our current treatments have evolved, and offers new insight into the use of keratinocyte apoptosis as a biomarker which may help to optimise UV treatment in the future. When combined with a systems biology approach, this potential biomarker may provide insight into which wavelengths of UV are the most effective in clearing psoriasis, allowing a more rational and potentially an individually tailored approach to optimising phototherapy for psoriasis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
E. L. Speight, and P. M. Farr, Erythemal and therapeutic response of psoriasis to PUVA using high-dose UVA, Br. J. Dermatol., 1994, 131(5), 667–672.
R. J. Turner, D. Walshaw, B. L. Diffey, and P. M. Farr, A controlled study of ultraviolet A sunbed treatment of psoriasis, Br. J. Dermatol., 2000, 143(5), 957–963.
S. Das, J. J. Lloyd, D. Walshaw, B. L. Diffey, and P. M. Farr, Response of psoriasis to sunbed treatment: comparison of conventional ultraviolet a lamps with new higher ultraviolet B-emitting lamps, Br. J. Dermatol., 2002, 147(5), 966–972.
R. S. Stern, and E. J. Lunder, Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis, Arch. Dermatol., 1998, 134(12), 1582–1585.
T. R. Coven, L. H. Burack, R. Gilleaudeau, M. Keogh, M. Ozawa, and J. G. Krueger, Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B, Arch. Dermatol., 1997, 133(12), 1514–1522.
P. M. Gordon, B. L. Diffey, J. N. Matthews, and P. M. Farr, A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis, J. Am. Acad. Dermatol., 1999, 41(5), 728–732.
S. M. Kirke, S. Lowder, J. J. Lloyd, B. L. Diffey, J. N. Matthews, and P. M. Farr, A randomized comparison of selective broadband UVB and narrowband UVB in the treatment of psoriasis, J. Invest. Dermatol., 2007, 127(7), 1641–1646.
P. Asawanonda, R. R. Anderson, Y. Chang, and C. R. Taylor, 308 nm excimer laser for the treatment of psoriasis: a dose-response study, Arch. Dermatol., 2000, 136(5), 619–624.
S. R. Feldman, B. G. Mellen, T. S. Housman, R. E. Fitzpatrick, R. G. Geronemus, and P. M. Friedman, et al., Efficacy of the 308 nm excimer laser for treatment of psoriasis: results of a multicenter study, J. Am. Acad. Dermatol., 2002, 46(6), 900–906.
W. Gerber, B. Arheilger, T. A. Ha, J. Hermann, and H. M. Ockenfels, Ultraviolet B 308 nm excimer laser treatment of psoriasis: a new phototherapeutic approach, Br. J. Dermatol., 2003, 149(6), 1250–1258.
K. Kollner, M. B. Wimmershoff, C. Hintz, M. Landthaler, and U. Hohenleutner, Comparison of the 308 nm excimer laser and a 308 nm excimer lamp with 311 nm narrowband ultraviolet B in the treatment of psoriasis, Br. J. Dermatol., 2005, 152(4), 750–754.
J. A. Parrish, and K. F. Jaenicke, Action spectrum for phototherapy of psoriasis, J. Invest. Dermatol., 1981, 76(5), 359–362.
S. C. Weatherhead, P. M. Farr, D. Jamieson, J. S. Hallinan, J. J. Lloyd, and A. Wipat, et al., Keratinocyte apoptosis in epidermal remodeling and clearance of psoriasis induced by UV radiation, J. Invest. Dermatol., 2011, 131(9), 1916–1926.
I. Man, R. S. Dawe, J. Ferguson, and S. H. Ibbotson, An intraindividual study of the characteristics of erythema induced by bath and oral methoxsalen photochemotherapy and narrowband ultraviolet B, Photochem. Photobiol., 2003, 78(1), 55–60.
P. M. Gordon, P. J. Saunders, B. L. Diffey, and P. M. Farr, Phototesting prior to narrowband (TL-01) ultraviolet B phototherapy, Br. J. Dermatol., 1998, 139(5), 811–814.
A. F. McKinlay, and B. L. Diffey, A reference action spectrum for ultra-violet induced erythema in human skin. in Human Exposure to Ultraviolet Radiation: Risks and Regulations, 1987, pp. 83–87.
B. L. Diffey, Observed and predicted minimal erythema doses: a comparative study, Photochem. Photobiol., 1994, 60(4), 380–382.
A. R. Webb, H. Slaper, P. Koepke, and A. W. Schmalwieser, Know your standard: clarifying the CIE erythema action spectrum, Photochem. Photobiol., 2011, 87(2), 483–486.
P. M. Farr, and B. L. Diffey, The erythemal response of human skin to ultraviolet radiation, Br. J. Dermatol., 1985, 113(1), 65–76.
R. B. Setlow, The wavelengths in sunlight effective in producing skin cancer: a theoretical analysis, Proc. Natl. Acad. Sci. U. S. A., 1974, 71(9), 3363–3366.
A. R. Young, C. A. Chadwick, G. I. Harrison, O. Nikaido, J. Ramsden, and C. S. Potten, The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema, J. Invest. Dermatol., 1998, 111(6), 982–988.
S. L. Walker, and A. R. Young, An action spectrum (290–320 nm) for TNFalpha protein in human skin in vivo suggests that basal-layer epidermal DNA is the chromophore, Proc. Natl. Acad. Sci. U. S. A., 2007, 104(48), 19051–19054.
F. R. de Gruijl, J. C. van der Leun, Estimate of the wavelength dependency of ultraviolet carcinogenesis in humans and its relevance to the risk assessment of a stratospheric ozone depletion, Health Phys., 1994, 67(4), 319–325.
D. L. Damian, Y. J. Matthews, T. A. Phan, and G. M. Halliday, An action spectrum for ultraviolet radiation-induced immunosuppression in humans, Br. J. Dermatol., 2011, 164(3), 657–659.
L. D. Sun, W. Li, S. Yang, X. Fan, K. L. Yan, and Y. H. Liang, et al., Evidence for a novel psoriasis susceptibility locus at 9q33–9q34 in Chinese Hans, J. Invest. Dermatol., 2007, 127(5), 1140–1144.
R. J. Flockhart, B. L. Diffey, P. M. Farr, J. Lloyd, and N. J. Reynolds, NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure, FASEB J., 2008, 22(12), 4218–4227.
J. K. Wagner, E. J. Parra, L. Norton H, C. Jovel, and M. D. Shriver, Skin responses to ultraviolet radiation: effects of constitutive pigmentation, sex, and ancestry, Pigm. Cell Res., 2002, 15(5), 385–390.
T. Ha, H. Javedan, K. Waterston, L. Naysmith, and J. L. Rees, The relationship between constitutive pigmentation and sensitivity to ultraviolet radiation induced erythema is dose-dependent, Pigm. Cell Res., 2003, 16(5), 477–479.
B. Bianchi, P. Campolmi, L. Mavilia, A. Danesi, R. Rossi, and P. Cappugi, Monochromatic excimer light (308 nm): an immunohistochemical study of cutaneous T cells and apoptosis-related molecules in psoriasis, J. Eur. Acad. Dermatol. Venereol., 2003, 17(4), 408–413.
A. Menter, N. J. Korman, C. A. Elmets, S. R. Feldman, J. M. Gelfand, and K. B. Gordon, et al., Guidelines of care for the management of psoriasis and psoriatic arthritis: section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy, J. Am. Acad. Dermatol., 2010, 62(1), 114–135.
S. M. Goldinger, R. Dummer, P. Schmid, M. Prinz Vavricka, G. Burg, and S. Lauchli, Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris, Dermatology, 2006, 213(2), 134–139.
M. Meinhardt, R. Krebs, A. Anders, U. Heinrich, and H. Tronnier, Absorption spectra of human skin in vivo in the ultraviolet wavelength range measured by optoacoustics, Photochem. Photobiol., 2009, 85(1), 70–77.
R. Takasawa, H. Nakamura, T. Mori, and S. Tanuma, Differential apoptotic pathways in human keratinocyte HaCaT cells exposed to UVB and UVC, Apoptosis, 2005, 10(5), 1121–1130.
K. Storbeck, E. Holzle, N. Schurer, P. Lehmann, and G. Plewig, Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis, J. Am. Acad. Dermatol., 1993, 28(2), 227–231.
H. van Weelden, E. Young, J. C. van der Leun, Therapy of psoriasis: comparison of photochemotherapy and several variants of phototherapy, Br. J. Dermatol., 1980, 103(1), 1–9.
I. B. Walters, L. H. Burack, T. R. Coven, P. Gilleaudeau, and J. G. Krueger, Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris, J. Am. Acad. Dermatol., 1999, 40(6), 893–900.
M. Weischer, A. Blum, F. Eberhard, M. Rocken, and M. Berneburg, No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study, Acta Derm.-Venereol., 2004, 84(5), 370–374.
A. Young, Carcinogenicity of UVB phototherapy assessed, Lancet, 1995, 345(8962), 1431–1432.
P. M. Farr, J. E. Besag, and B. L. Diffey, The time course of UVB and UVC erythema, J. Invest. Dermatol., 1988, 91(5), 454–457.
B. L. Diffey, P. M. Farr, and A. M. Oakley, Quantitative studies on UVA-induced erythema in human skin, Br. J. Dermatol., 1987, 117(1), 57–66.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as part of a themed issue on current topics in photodermatology.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Weatherhead, S.C., Farr, P.M. & Reynolds, N.J. Spectral effects of UV on psoriasis. Photochem Photobiol Sci 12, 47–53 (2013). https://doi.org/10.1039/c2pp25116g
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c2pp25116g